Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Coherus Bio
(NQ:
CHRS
)
1.260
-0.290 (-18.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Coherus Bio
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
January 22, 2024
Coherus BioSciences agreed to sell its ophthalmology franchise for $170M to Sandoz. This aligns with CHRS' focus on oncology and will help reduce debt and overhead costs.
Via
Benzinga
Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?
January 22, 2024
Cartesian Therapeutics stock is falling on Monday as investors react to a delisting notice for RNAC shares due to its low trading price.
Via
InvestorPlace
Why Is B. Riley Financial (RILY) Stock Down 11% Today?
January 22, 2024
B. Riley Financial stock is falling on Monday as RILY investors react to reports of an SEC probe and the company's stance on the news.
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Is Coherus BioSciences (CHRS) Stock Up 17% Today?
January 22, 2024
Coherus BioSciences stock is rising on Monday as CHRS investors react to a $170 million divestment of its CIMERLI ophthalmology franchise.
Via
InvestorPlace
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 22, 2024
We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday!
Via
InvestorPlace
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal
January 22, 2024
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 18, 2024
Via
Benzinga
Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium
January 18, 2024
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
January 10, 2024
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus Announces U.S. Launch of LOQTORZI™
January 02, 2024
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 29, 2023
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session
December 29, 2023
U.S. stock futures were slightly higher this morning, with the Dow Jones futures gaining around 15 points on Thursday. Shares of FLJ Group Limited(NASDAQ: FLJ) rose sharply in pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Coherus BioSciences Stock Jumped Today
December 28, 2023
Coherus finally received FDA approval for its Udenyca OnBody injector system.
Via
The Motley Fool
Exposures
Product Safety
Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher
December 27, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 27, 2023
Via
Benzinga
Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December
December 27, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Coherus BioSciences Stock Is Climbing Today
December 27, 2023
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher Wednesday after the company announced the FDA approval of its pegfilgrastim delivery device, Udenyca Onbody.
Via
Benzinga
Exposures
Product Safety
US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY
December 27, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while...
Via
Benzinga
Topics
Stocks
Exposures
Product Safety
US Equities
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
December 27, 2023
Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 27, 2023
Via
Benzinga
S&P 500, Nasdaq Set For Wobbly Open As Santa Claus Rally Fades: Analyst Sees Final Trading Sessions As 'Last Great Buying Opportunity'
December 27, 2023
U.S. stocks may face challenges in maintaining their upward momentum on Wednesday, as index futures suggest a flat start. In the absence of significant catalysts, the market might experience a lack of...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
December 27, 2023
U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday
December 27, 2023
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 26, 2023
Via
Benzinga
Coherus BioSciences Stock Is Soaring After-Hours - Here's Why
December 26, 2023
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher in Tuesday's after-hours session following the company's announcement of the U.S.
Via
Benzinga
Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
December 26, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.